Equities
Health CarePharmaceuticals and Biotechnology
  • Price (CHF)39.77
  • Today's Change-0.405 / -1.01%
  • Shares traded70.89k
  • 1 Year change+50.13%
  • Beta--
Data delayed at least 20 minutes, as of Nov 14 2024 16:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue9,9799,3069,678
OPERATING EXPENSES
Cost of revenue total5,2884,8014,992
Selling, general and admin. expenses, total2,3602,1272,127
Depreciation/amortization------
Unusual expense(income)891338304
Other operating expenses, total150(30)(41)
Total operating expense9,6048,0678,284
Operating income3751,2391,394
Other, net(20)(34)(10)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1301,1021,313
Provision for income taxes50252403
Net income after taxes80850910
Minority interest(3)(2)(2)
Net income before extra. Items77848908
Total extraordinary items------
Net income77848908
Inc.avail. to common excl. extra. Items77848908
Inc.avail. to common incl. extra. Items77848908
EPS RECONCILIATION
Basic/primary weighted average shares430431431
Basic/primary eps excl. extra items0.181.972.11
Basic/primary eps incl. extra items0.181.972.11
Dilution adjustment------
Diluted weighted average shares431431431
Diluted eps excl. extra items0.181.972.11
Diluted eps incl. extra items0.181.972.11
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.5300
Gross dividend - common stock23000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1988262
SUPPLEMENTAL INCOME
Depreciation, supplemental251236261
Total special items905338304
NORMALISED INCOME
Normalized income before taxes1,0351,4401,617
Effect of special items on income taxes(234)7793
Income tax excluding impact of special items(184)329496
Normalized income after tax1,2191,1111,121
Normalized income avail. to common1,2161,1091,119
Basic normalized EPS2.832.572.60
Diluted normalized EPS2.822.572.60
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.